DEC 23, 2016 1:42 PM PST

Men Sue J&J Over Breast Growth Side Effect


A Johnson & Johnson drug approved for the treatment of a handful of mood or mental disorders is coming under fire for causing unwanted male breast development.

Image credit:

Risperdal was approved in the US market in the early 1990s. It is prescribed mainly as an antipsychotic, for the treatment of bipolar disorder and schizophrenia. It is also prescribed as a mood stabilizer for irritability in people with autism.

However, among the drug’s side effects, patients say there another one that they were not told about: gynecomastia, or development of male breasts. Specifically a group of men who took the drug in the early 2000’s say that gynecomastia was not disclosed to them clearly.

In total, the new lawsuit will represent 13,000 patients who Jason Itkin, the lead lawyer, say were “injured by the drug.”

Among the patients is Eddie Bible. Bible recounts having taken Risperdal for the treatment of anxiety and bipolar disorder when he was 13. "They put me on this Risperdal. The doctors said, 'Well, Risperdal was helping some.' To me, it didn't really help, because a year and a half later, I had gynecomastia."

Bible’s side effects were so bad that he thought at one point he would have to get a training bra. He also vividly recalls being publicly shamed for his appearance. "I'd go to the locker room, and people would point and stare. Everybody picking on you for being a boy with boobs. ... It's just ... depressing,” said Bible.

It wasn’t until 2006 that the manufacturers disclosed gynecomastia as a side effect of Risperdal. And that was too little too late for Bible and the thousands of others who had already taken the drug without full knowledge of how the drug would affect their bodies. "If I knew what the side effects would be of the medication, I would have never taken it," Bible said

"Looking back on it, I feel like an experiment," he said.

This is not the first time Risperdal has been in the legal spotlight. In 2012, Johnson & Johnson settled a multimillion dollar lawsuit for promoting the drug can treat dementia without sufficient evidence or approval.

For Bible and others like him, suing Johnson & Johnson for disfigurement goes beyond monetary compensation. They want to make sure that a drug company that helps treat conditions in kids live up to the highest standards so as to avoid future damages, the likes of which they’ve had to endure.

However, the road to getting compensation may be harder than expected. Earlier this week, a Pennsylvania judge ruled to dismiss the case on the grounds of "inadequate" expert testimony. The decision is currently being appealed.

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at
You May Also Like
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience ...
FEB 05, 2020
Clinical & Molecular DX
FEB 05, 2020
A new CRISPR-based test for coronavirus infections
A surge in infections has caused panic surrounding the coronavirus (2019-nCoV) outbreak to reach a fever pitch. Despite ...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and ...
MAR 19, 2020
MAR 19, 2020
All You Need to Know About Coronavirus (CoVID-19)
A new coronavirus, first identified in China in December 2019, has caused an outbreak of respiratory illness that was re ...
MAR 25, 2020
Clinical & Molecular DX
MAR 25, 2020
A coronavirus testing kit with glow-in-the-dark Mango?
A group of Canadian researchers is responding to a desperate need for COVID-19 diagnostic kits with their fluorescent im ...
JUN 07, 2020
Genetics & Genomics
JUN 07, 2020
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
When children have a rare genetic disease and do not have access to whole-genome sequencing and the analysis it requires ...
Loading Comments...